Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Haematologica
|
June 6, 2024
Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments
Marine Baron, Karim Labreche, Marianne Veyri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 9, 2025
Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC
Baptiste Abbar, Karim Labreche, Jacques Cadranel, et al.
Cancer Cell
|
April 5, 2024
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma
Avishay Spitzer, Simon Gritsch, Masashi Nomura, et al.
The Lancet. Oncology
|
November 1, 2025
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
Timothy F Cloughesy, Martin J van den Bent, Mehdi Touat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma
Salah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret, et al.
Genome Biology
|
August 6, 2024
Microsatellite instability at U2AF-binding polypyrimidic tract sites perturbs alternative splicing during colorectal cancer initiation
Vincent Jonchère, Hugo Montémont, Enora Le Scanf, et al.
Neuro-Oncology
|
October 23, 2024
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions
Mary Jane Lim-Fat, Julie Bennett, Quinn Ostrom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data
Tulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
Neuro-Oncology
|
August 19, 2025
Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions
Patrick Y Wen, Michael Weller, Eudocia Q Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2019
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial
Patrick Y Wen, Mehdi Touat, Brian M Alexander, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Haematologica
|
June 6, 2024
Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments
Marine Baron, Karim Labreche, Marianne Veyri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 9, 2025
Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC
Baptiste Abbar, Karim Labreche, Jacques Cadranel, et al.
Cancer Cell
|
April 5, 2024
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma
Avishay Spitzer, Simon Gritsch, Masashi Nomura, et al.
The Lancet. Oncology
|
November 1, 2025
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
Timothy F Cloughesy, Martin J van den Bent, Mehdi Touat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma
Salah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret, et al.
Genome Biology
|
August 6, 2024
Microsatellite instability at U2AF-binding polypyrimidic tract sites perturbs alternative splicing during colorectal cancer initiation
Vincent Jonchère, Hugo Montémont, Enora Le Scanf, et al.
Neuro-Oncology
|
October 23, 2024
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions
Mary Jane Lim-Fat, Julie Bennett, Quinn Ostrom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data
Tulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
Neuro-Oncology
|
August 19, 2025
Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions
Patrick Y Wen, Michael Weller, Eudocia Q Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2019
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial
Patrick Y Wen, Mehdi Touat, Brian M Alexander, et al.
Page
of 10